A randomized trial of AmBisome® monotherapy and combination of AmBisome® and miltefosine for the treatment of VL in HIV positive patients in India

This is phase 3 randomised controlled trial based in Bihar, India to generate evidence for the best treatment for patients with visceral leishmaniasis who are co-infected with HIV. A combination of 2 drugs will be tested in parallel to a mono therapy, while evidence on disease evolution and viral loads will also be gathered.